361 related articles for article (PubMed ID: 32232583)
1. Mitochondria-targeted phosphorescent cyclometalated iridium(III) complexes: synthesis, characterization, and anticancer properties.
Li Y; Liu B; Xu CX; He L; Wan YC; Ji LN; Mao ZW
J Biol Inorg Chem; 2020 Jun; 25(4):597-607. PubMed ID: 32232583
[TBL] [Abstract][Full Text] [Related]
2. Anticancer effect evaluation in vitro and in vivo of iridium(III) polypyridyl complexes targeting DNA and mitochondria.
Zhang H; Tian L; Xiao R; Zhou Y; Zhang Y; Hao J; Liu Y; Wang J
Bioorg Chem; 2021 Oct; 115():105290. PubMed ID: 34426145
[TBL] [Abstract][Full Text] [Related]
3. Coumarin-appended phosphorescent cyclometalated iridium(iii) complexes as mitochondria-targeted theranostic anticancer agents.
Ye RR; Tan CP; Ji LN; Mao ZW
Dalton Trans; 2016 Aug; 45(33):13042-51. PubMed ID: 27139504
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, photophysical and anticancer properties of mitochondria-targeted phosphorescent cyclometalated iridium(III) N-heterocyclic carbene complexes.
Li Y; Wang KN; He L; Ji LN; Mao ZW
J Inorg Biochem; 2020 Apr; 205():110976. PubMed ID: 31926377
[TBL] [Abstract][Full Text] [Related]
5. Highly potent half-sandwich iridium and ruthenium complexes as lysosome-targeted imaging and anticancer agents.
Li J; Tian Z; Xu Z; Zhang S; Feng Y; Zhang L; Liu Z
Dalton Trans; 2018 Nov; 47(44):15772-15782. PubMed ID: 30357192
[TBL] [Abstract][Full Text] [Related]
6. Cyclometalated iridium(III)-guanidinium complexes as mitochondria-targeted anticancer agents.
Song XD; Kong X; He SF; Chen JX; Sun J; Chen BB; Zhao JW; Mao ZW
Eur J Med Chem; 2017 Sep; 138():246-254. PubMed ID: 28668477
[TBL] [Abstract][Full Text] [Related]
7. Identification of two mitochondrial-targeting cyclometalated iridium(III) complexes as potent anti-glioma stem cells agents.
Peng W; Hegazy AM; Jiang N; Chen X; Qi HX; Zhao XD; Pu J; Ye RR; Li RT
J Inorg Biochem; 2020 Feb; 203():110909. PubMed ID: 31689591
[TBL] [Abstract][Full Text] [Related]
8. Guanidine-modified cyclometalated iridium(III) complexes for mitochondria-targeted imaging and photodynamic therapy.
Song XD; Chen BB; He SF; Pan NL; Liao JX; Chen JX; Wang GH; Sun J
Eur J Med Chem; 2019 Oct; 179():26-37. PubMed ID: 31233920
[TBL] [Abstract][Full Text] [Related]
9. Cyclometalated iridium(III) complexes as mitochondria-targeted anticancer and antibacterial agents to induce both autophagy and apoptosis.
Chen BB; Pan NL; Liao JX; Huang MY; Jiang DC; Wang JJ; Qiu HJ; Chen JX; Li L; Sun J
J Inorg Biochem; 2021 Jun; 219():111450. PubMed ID: 33826973
[TBL] [Abstract][Full Text] [Related]
10. Cyclometalated iridium(iii) N-heterocyclic carbene complexes as potential mitochondrial anticancer and photodynamic agents.
Li Y; Liu B; Lu XR; Li MF; Ji LN; Mao ZW
Dalton Trans; 2017 Aug; 46(34):11363-11371. PubMed ID: 28812748
[TBL] [Abstract][Full Text] [Related]
11. Anticancer and antibacterial activity in vitro evaluation of iridium(III) polypyridyl complexes.
Yi QY; Zhang WY; He M; Du F; Wang XZ; Wang YJ; Gu YY; Bai L; Liu YJ
J Biol Inorg Chem; 2019 Mar; 24(2):151-169. PubMed ID: 30564887
[TBL] [Abstract][Full Text] [Related]
12. Cyclometalated iridium(iii) complexes induce mitochondria-derived paraptotic cell death and inhibit tumor growth in vivo.
He L; Wang KN; Zheng Y; Cao JJ; Zhang MF; Tan CP; Ji LN; Mao ZW
Dalton Trans; 2018 May; 47(20):6942-6953. PubMed ID: 29721561
[TBL] [Abstract][Full Text] [Related]
13. Fluorinated cyclometalated iridium(iii) complexes as mitochondria-targeted theranostic anticancer agents.
Ouyang M; Zeng L; Huang H; Jin C; Liu J; Chen Y; Ji L; Chao H
Dalton Trans; 2017 May; 46(20):6734-6744. PubMed ID: 28488721
[TBL] [Abstract][Full Text] [Related]
14. Tracking mitochondrial dynamics during apoptosis with phosphorescent fluorinated iridium(iii) complexes.
Zhang C; Qiu K; Liu C; Huang H; Rees TW; Ji L; Zhang Q; Chao H
Dalton Trans; 2018 Oct; 47(37):12907-12913. PubMed ID: 30117504
[TBL] [Abstract][Full Text] [Related]
15. Valproic Acid-Functionalized Cyclometalated Iridium(III) Complexes as Mitochondria-Targeting Anticancer Agents.
Ye RR; Cao JJ; Tan CP; Ji LN; Mao ZW
Chemistry; 2017 Oct; 23(60):15166-15176. PubMed ID: 28833658
[TBL] [Abstract][Full Text] [Related]
16. Cyclometalated iridium(III) dithioformic acid complexes as mitochondria-targeted imaging and anticancer agents.
Wu Y; Liu J; Shao M; Zhang P; Song S; Yang G; Liu X; Liu Z
J Inorg Biochem; 2022 Aug; 233():111855. PubMed ID: 35576884
[TBL] [Abstract][Full Text] [Related]
17. Alkyl chain-modified cyclometalated iridium complexes as tunable anticancer and imaging agents.
Laha P; De U; Chandra F; Dehury N; Khullar S; Kim HS; Patra S
Dalton Trans; 2018 Nov; 47(44):15873-15881. PubMed ID: 30358775
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, characterization and anticancer activity in vitro and in vivo evaluation of an iridium (III) polypyridyl complex.
Yi QY; Wan D; Tang B; Wang YJ; Zhang WY; Du F; He M; Liu YJ
Eur J Med Chem; 2018 Feb; 145():338-349. PubMed ID: 29331805
[TBL] [Abstract][Full Text] [Related]
19. Highly Charged, Cytotoxic, Cyclometalated Iridium(III) Complexes as Cancer Stem Cell Mitochondriotropics.
Laws K; Eskandari A; Lu C; Suntharalingam K
Chemistry; 2018 Oct; 24(57):15205-15210. PubMed ID: 30052298
[TBL] [Abstract][Full Text] [Related]
20. Ferrocene-Appended Iridium(III) Complexes: Configuration Regulation, Anticancer Application, and Mechanism Research.
Ge X; Chen S; Liu X; Wang Q; Gao L; Zhao C; Zhang L; Shao M; Yuan XA; Tian L; Liu Z
Inorg Chem; 2019 Oct; 58(20):14175-14184. PubMed ID: 31559820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
